Interleukin-10, T regulatory cells and specific allergy treatment

Clinical and Experimental Allergy

Volumn 34, Issue 3, 2004, Pages 328-331

  Blaser, K ^a   Akdis, C A ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 10;

ALLERGY; B LYMPHOCYTE; CELLULAR IMMUNITY; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOTHERAPY; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE;

DESENSITIZATION, IMMUNOLOGIC; GLUCOCORTICOIDS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULINS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; SKIN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1642344677     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.01909.x     Document Type: Editorial

References (39)

1. Müller UR, Mosbech H. Position paper: immunotherapy with hymenoptera venoms. Allergy 1993; 48:36-46.
2. Bousquet J, Lockey RF, Mailing HJ. WHO position paper. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. Allergy 1998; 53:S1-42.
3. Aalberse RC, Van der Gaag R, van Leuwen J. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 1983; 130:722-6.
4. Creticos PS, Franklin Adkinson Jr N, Kagey-Sabotka A et al. Nasal challenge with ragweed in hay fever patients: effect of immunotherapy. J Clin Invest 1983; 76:2247-53.
5. Akdis CA, Blaser K. Mechanisms of allergen-specific immunotherapy. Allergy 2000; 55:522-30.
6. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin-4 production in CD4 T cells from allergic individuals. J Exp Med 1993; 178:2123-30.
7. Durham SR, Walker SM, Varga E-V et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341:468-75.
8. 2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 1996; 98:1676-83.
9. Akdis CA, Blesken T, Akdis M, Wüthrich B, Blaser K. Role of IL-10 in specific immunotherapy. J Clin Invest 1998; 102:98-106.
10. Akdis CA, Blaser K. IL-10 induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. Faseb J 1999; 13:603-9.
11. 2 induces specific T cell anergy in bee sting allergic patients. J Allergy Clin Immunol 1998; 101:747-54.
12. Marcotte GV, Braun CM, Norman PS et al. Effects of peptide therapy on ex vivo T cell responses. J Allergy Clin Immunol 1998; 101:506-13.
13. Oldfield WL, Larche M, Kay AB. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 2002; 360:47-53.
14. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389:737-42.
15. Cobbold S, Waldmann H. Infectious tolerance. Curr Opin Immunol 1998; 10:518-24.
16. Jutel M, Akdis M, Budak F et al. IL-10 and TGF-β cooperate in regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33:1205-14.
17. Savolainen J, Laaksonen K, Rantio-Lehtimäki A, Terho EO. Increased expression of allergen-induced in vitro interleukin-10 and interleukin-18 mRNA in peripheral blood mononuclear cells of allergic rhinitis patients after specific immunotherapy. Clin Exp Allergy 2004; 34:413-9.
18. Gayo A, Mozo L, Suarez A, Tunon A, Lahoz C, Gutierrez C. Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse. J Neuroimmunol 1998; 15:122-30.
19. Verhoef CM, van Roon JA, Vianen ME, Lafeber FP, Bijlsma JW. The immune suppressive effect of dexamethasone in rheumatoid arthritis is accompanied by upregulation of interleukin-10 and by differential changes in interferon-y and interleukin-4. Ann Rheum Dis 1999; 58:49-54.
20. Stelmach I, Jerzynska J, Kuna PA. A randomized, double-blind trial of the effect of glucocorticoid, anti-leukotriene and b-agonist treatment on IL-10 serum levels in children with asthma. Clin Exp Allergy 2002; 32:264-9.
21. Mozo L, Suárez A, Gutiérrez C. Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes. Clin Exp Allergy 2004; 34:406-12.
22. Scheinman R, Cogswell P, Lofquist A, Baldwin A. Role of transcriptional activation of Iκbα in mediation of immunosuppression by glucocorticoids. Science 1995; 270:283-6.
23. Akdis CA, Blesken T, Akdis M, Alkan SS, Heusser CH, Blaser K. Glucocorticoids inhibit human antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro. Eur J Immunol 1997; 27:2351-7.
24. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-64.
25. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001; 166:5530-9.
26. Barrat FJ, Cua DJ, Boonstra A et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195:603-16.
27. Punnonen J, De Waal Malefyt R, Van Vlasselaer P, Gauchat J-F, De Vries JE. IL-10 and viral IL-10 prevent IL-4-indiced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol 1993; 151:1280-9.
28. Sonoda E, Matsumoto R, Hitoshi Y et al. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med 1989; 170:1415-20.
29. Walker C, Virchow J-C, Bruijnzeel PLB, Blaser K. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991; 146:1829-35.
30. Schleimer RP, Derse CP, Friedman B et al. Regulation of human basophil mediator release by cytokines. I. Interaction with anti-inflammatory steroids. J Immunol 1989; 143:1310-27.
31. Marshall JS, Leal-Berumen I, Nielsen L, Glibetic M, Jordana M. Interleukin (IL)-10 Inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J Clin Invest 1996; 97:1122-8.
32. Schandane L, Alonso-Vega C, Willems F et al. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol 1994; 152:4368-74.
33. Ohkawara Y, Lim KG, Glibetic M et al. CD40 expression by human peripheral blood eosinophils. J Clin Invest 1996; 97:1761-6.
34. Jutel M, Watanabe T, Klunker S et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001; 413:420-5.
35. Akdis CA, Blaser K. Histamine in the immmune regulation of allergic inflammation. J Allergy Clin Immunol 2003; 112:15-22.
36. Kunzmann S, Mantel P-Y, Wohlfahrt JG, Akdis M, Blaser K, Schmidt-Weber CB. Histamine enhances TGF-beta1-mediated suppression of Th2 responses. FASEB J 2003; 17:1089-95.
37. Akdis CA, Joss A, Akdis M, Faith A, Blaser K. A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J 2000; 14:1666-9.
38. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
39. Finbloom DS, Winestock KD. IL-10 induces the tyrosine phosphorylation of Tyk2 and Jak1 and the differential assembly of STAT1α and STAT3 complexes in human T cells and monocytes. J Immunol 1995; 155:1979-90.